Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Oct 04, 2023 5:15pm
82 Views
Post# 35669875

RE:RE:RE:RE:RE:Proof by U.S. Federal Law: We have Pfizer as a customer

RE:RE:RE:RE:RE:Proof by U.S. Federal Law: We have Pfizer as a customer First off, FDA doesn't use terminology such as approved, rejected, secondly when labs first applied for the FDA DMF they were the only other company other than JAZZ on the pharma compass list even though they had not had a site visit or accepted application by the FDA, that came about 1 yr later, lastly any pharmaceutical company operating in North America looking to commercialize a cannabinoid drug today only has one option, one company who can produce on mass TODAY with required certain for pharma applications other than JAZZ, a company who previously pumped 50m of canadidol a quarter outta Barrie as wholesale bulk...I'd love to see evidence on the contrary I've yet to find any myself....multiple global pharma corps as stated previously in PR's. ANDA, 505b, and recently announced top three brazilian generic Corp...details will emerge when commercialization is near..I'm frustrated with SP also..but wheels are in motion.
<< Previous
Bullboard Posts
Next >>